Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Yamo Pharmaceuticals
yamo pharmaceuticals is developing l1-79, a novel therapy that targets the core symptoms of autism and has been well-tolerated by clinical trial patients to-date. the mechanism of action for l1-79 addresses both the central nervous system and metabolic symptoms of autism.
Frequently asked questions about Yamo Pharmaceuticals
Let us help answer the most common questions you might have.
Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free